Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT00000270

Brain Imaging: Cocaine Effects & Medication Development - 5

Brain Imaging: Cocaine Effects & Medication Development

Status
Withdrawn
Phase
Phase 4
Study type
Interventional
Enrollment
0 (actual)
Sponsor
New York State Psychiatric Institute · Academic / Other
Sex
All
Age
18 Years – 48 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to define temporal profile of brain activation (rCBF) using Xenon-SPECT and O 15-PET.

Conditions

Interventions

TypeNameDescription
DRUGCocaine

Timeline

Start date
1995-12-30
Primary completion
1995-12-30
Completion
1995-12-30
First posted
1999-09-21
Last updated
2017-08-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00000270. Inclusion in this directory is not an endorsement.

Brain Imaging: Cocaine Effects & Medication Development - 5 (NCT00000270) · Clinical Trials Directory